Cancer

News

NHS funds BMS' Opdivo to prevent skin cancer returning

NICE has recommended interim NHS funding for Bristol-Myers Squibb’s cancer immunotherapy, Opdivo to prevent early stage skin cancer from recurring, overturning a decision earlier this year

News

EU approves Kyowa Kirin's drug for rare lymphoma

The European Commission has approved Poteligeo (mogamulizumab), a treatment for rare types of non-Hodgkin’s lymphoma.

News

Bayer/Loxo drug approved in cancers with certain mutation

The FDA has approved Bayer and Loxo’s Vitrakvi (larotrectinib) for adults and children whose cancers have a specific genetic feature, or biomarker.

News

NHS lags best performers in cancer care - report

The performance of NHS cancer services in England is lagging behind those of comparable countries, according to a new report.

News

Mundipharma's Neulasta biosimilar approved in EU

A second cut-price biosimilar of Amgen’s Neulasta (pegfilgrastim) long-acting white blood cell booster is to hit the EU market after the European Commission approved Mundipharma’s Pelmeg.

News

UK biotech aims to cut costs with digital and robotics inves...

Gene and cell therapy firm Oxford Biomedica is to invest £4 million to build digital and robotics capabilities that will help manufacture the next generation of cutting edge therapies.

NHS funds BMS' Opdivo to prevent skin cancer returning

EU approves Kyowa Kirin's drug for rare lymphoma

Bayer/Loxo drug approved in cancers with certain mutation

NHS lags best performers in cancer care - report

Mundipharma's Neulasta biosimilar approved in EU

UK biotech aims to cut costs with digital and robotics inves...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Cancer

Editor's Picks